The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Category: LifeArc
200,000 people in the UK have what is considered a ‘hidden’ lung condition
Genentech’s Pulmozyme could also treat other respiratory infections and conditions
Around one in five dementia hospitalisations are due to potentially preventable causes
The mosquito-borne viral disease is responsible for an estimated 390 million cases globally
Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK
The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours
The progressive and incurable brain disorder currently affects approximately 100 patients worldwide